Back to results
US 7,094,763 B2Granted
Substituted fused heterocyclic C-glycosides
AssigneeJanssen Pharaceutica, N.V.
InventorsPhilip Rybczynski, Maud Urbanski, Xiaoyan Zhang
Life of this patent
Estimating the term…
Abstract
This invention relates to substituted fused heterocyclic C-glycosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.
Claims22
A compound of formula IV:
- wherein:
- one of the dashed lines between NR1 and X or between X and Y is present and if present such dashed lines represent a double bond, or alternatively both dashed lines are absent;
- two of V, M, and W are H and the third is
- R1 is H, or C1-4 alkyl;
- or, where the dashed line between NR1 and X is present, R1 is absent;
- X is N, C═O, CH, or C—Q—Z;
- Y is N—Q—Z or C—Q—Z, where X is N, C═O, or CH;
- Y is CH, where X is C—Q—Z;
- Q=—(CH2)n— where n=1 or 2;
- P=H, C1-7 acyl, or C1-6 alkoxycarbonyl;
- Z is substituted or unsubstituted, and is selected from C3-7 cycloalkyl, phenyl, a 5- or 6- membered heteroaryl having 1 or 2 heteroatoms independently selected from N, O, and S, a biaryl, a 9- or 10-membered fused bicyclyl, and a fused heterobicyclyl, wherein said fused heterobicyclyl has between 1 and 4 heteroatoms independently selected from N, O, and S;
- or a pharmaceutically acceptable salt, thereof.
9 more elements
Dependencies are inferred from the claim text.